JUNE 19-21, 2023
WASHINGTON, DC


Drug, Biomolecule, and Vaccine Delivery

Materials for Drug & Gene Delivery

Symposium Co-Chairs

Steven ZulloSteven Zullo
Program Director
National Institute of Biomedical Imaging and Bioengineering (NIBIB)/NIH

Thomas AnchordoquyExploiting the Refractory Response to Limit Off-Target Accumulation
Thomas Anchordoquy
Professor Department of Pharmaceutical Sciences, University of Colorado

Puneet TyagiPuneet Tyagi
Senior Scientist
AstraZeneca

2022 Key Speakers

Thomas AnchordoquyExploiting the Refractory Response to Limit Off-Target Accumulation
Thomas Anchordoquy
Professor Department of Pharmaceutical Sciences, University of Colorado

Puneet TyagiPuneet Tyagi
Senior Scientist
AstraZeneca

Sanghamitra MajumdarDevelopment of Standard Test Methods for Lipid Quantitation in Liposomal Drug Product
Sanghamitra Majumdar
Visiting Scientist, U.S. Food & Drug Administration

Presentations in this session focus on strategies for improving the delivery of traditional small molecule drugs, proteins such as monoclonal antibodies, or genetic material (RNA, DNA). The route of administration can be systemic (e.g., IV, oral) or local (e.g., IM, topical), with the goal of enhancing delivery beyond current approaches. The delivery improvement can be in terms of timing, control, or dosing, but may also address challenges associated with biological responses to the delivery vehicle such as toxicity and immunogenicity.

 

Topics & Application Areas

  • Sustained/controlled release
  • Ligand-mediated delivery
  • Improved accumulation at desired site
  • Stimulation of specific immune pathways
  • Avoidance of adverse effects and toxicity
  • Robust resistance to disease
  • Other
 

Sponsor & Exhibitor Opportunities
 

To receive announcements and news, please join our mailing list.

Click here to add this event to your calendar.
Sponsors & Partners
 
2022 SBIR/STTR AGENCY PARTNERS
SBIR/STTR Agency Partners